Fundz

NeoPhore Raises Additional £9.6M in Series B Extension Financing

PRIVATEFeb 01, 2024

Amount Raised

£9.6 Million

Round Type

Series B

CambridgeBiotechnology Research

Investors

Simon FiduciariaLifttNeva SGR2invest Ag3 B Future Health FundAstellas Venture ManagementClaris VenturesCpf Managed By Sixth Element Capital

Description

NeoPhore raised an additional £9.6M in a Series B extension financing round, bringing the total amount to £31.1M. The funding saw participation from existing syndicate CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, and the addition of three new investors – NEVA SGR, LIFTT, and Simon Fiduciaria. The company intends to further advance its drug discovery pipeline.

Quick answer

NeoPhore Ltd raised £9.6 Million in a Series B round, dated February 1, 2024. Investors: Simon Fiduciaria, Liftt, Neva SGR, 2invest Ag, 3 B Future Health Fund, Astellas Venture Management, Claris Ventures and Cpf Managed By Sixth Element Capital. NeoPhore Ltd is based in Cambridge, England, United Kingdom.

How much did NeoPhore Ltd raise?
NeoPhore Ltd raised £9.6 Million in a Series B round on February 1, 2024.
Who invested in NeoPhore Ltd?
Simon Fiduciaria, Liftt, Neva SGR, 2invest Ag, 3 B Future Health Fund, Astellas Venture Management, Claris Ventures and Cpf Managed By Sixth Element Capital are named as investors in this round.
What does NeoPhore Ltd do?
NeoPhore is creating novel small molecule immuno-oncology therapeutics.
Where is NeoPhore Ltd based and how big is it?
NeoPhore Ltd is based in Cambridge, England, United Kingdom.
Who are the decision-makers at NeoPhore Ltd?
Fundz holds 1 contact at NeoPhore Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as NeoPhore Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Baseimmune raised $11M (Series A) on February 26, 2024.
  • eFeed raised $10M (Seed) on February 21, 2024.
  • VRG Therapeutics raised $15M (Series B) on February 20, 2024.
  • Colipi raised $1.9M (Seed) on February 19, 2024.
  • FreezeM raised $14M (Series A) on February 15, 2024.
  • SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.

Who to call at NeoPhore Ltd, and when

A new round usually means NeoPhore Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeoPhore Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeoPhore Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeoPhore Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeoPhore Ltd

Location

Cambridge, England, United Kingdom

About

NeoPhore is creating novel small molecule immuno-oncology therapeutics. NeoPhore's drugs target genetic mechanisms that both clinical and lab validation studies suggest will promote neoantigen creation and diversity across numerous cancers. Alone or in combination with other cancer immunotherapies, drugs that spark cancer neoantigen creation are designed to stimulate the immune system and improve outcomes for patients who fail to benefit from the current generation of cancer immunity therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeoPhore Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for NeoPhore Ltd's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

NeoPhore Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.